Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-09
DOI
10.1038/srep13855
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel cysteine cathepsin inhibitor yields macrophage cell death and mammary tumor regression
- (2015) S J Salpeter et al. ONCOGENE
- Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization
- (2014) Min Yang et al. Molecular Cancer
- Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S
- (2014) Lisa Sevenich et al. NATURE CELL BIOLOGY
- Cysteine cathepsins and their potential in clinical therapy and biomarker discovery
- (2014) Marko Fonović et al. Proteomics Clinical Applications
- Imaging collagen degradation in vivo highlights a key role for M2-polarized macrophages in extracellular matrix degradation
- (2014) Daniel H Madsen et al. OncoImmunology
- Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization
- (2013) Donna M. Small et al. INTERNATIONAL JOURNAL OF CANCER
- Azidothymidine (AZT) leads to arterial stiffening and intima-media thickening in mice
- (2013) Laura Hansen et al. JOURNAL OF BIOMECHANICS
- Role for Cysteine Protease Cathepsins in Heart Disease
- (2012) Xian Wu Cheng et al. CIRCULATION
- Inter-cellular signaling network reveals a mechanistic transition in tumor microenvironment
- (2012) Yu Wu et al. Integrative Biology
- Patient specific proteolytic activity of monocyte-derived macrophages and osteoclasts predicted with temporal kinase activation states during differentiation
- (2012) Keon-Young Park et al. Integrative Biology
- Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
- (2012) Archie Bleyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macrophage cathepsin K promotes prostate tumor progression in bone
- (2012) M K Herroon et al. ONCOGENE
- Inhibition of Cathepsin K for Treatment of Osteoporosis
- (2012) Steven Boonen et al. Current Osteoporosis Reports
- Manipulating substrate and pH in zymography protocols selectively distinguishes cathepsins K, L, S, and V activity in cells and tissues
- (2011) Catera L. Wilder et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
- (2011) T. Shree et al. GENES & DEVELOPMENT
- Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions
- (2011) Damya Laoui et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- B cells and macrophages in cancer: yin and yang
- (2011) Alberto Mantovani NATURE MEDICINE
- Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model
- (2010) Benelita Tina Elie et al. BIOCHIMIE
- Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome
- (2010) Michael J. Campbell et al. BREAST CANCER RESEARCH AND TREATMENT
- The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer
- (2010) Eva Kolwijck et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
- (2010) V. Gocheva et al. GENES & DEVELOPMENT
- Specialized roles for cysteine cathepsins in health and disease
- (2010) Jochen Reiser et al. JOURNAL OF CLINICAL INVESTIGATION
- Triple-negative breast cancer--current status and future directions
- (2009) O. Gluz et al. ANNALS OF ONCOLOGY
- Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools
- (2009) Sylvie Desmarais et al. BIOLOGICAL CHEMISTRY
- Cathepsin K inhibitors for osteoporosis and potential off-target effects
- (2009) Dieter Brömme et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy.
- (2009) Wojciech Naumnik et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts
- (2009) C. L. Roland et al. MOLECULAR CANCER THERAPEUTICS
- Cathepsin K inhibitors as treatment of bone metastasis
- (2009) Céline Le Gall et al. Current Opinion in Supportive and Palliative Care
- Usefulness of Serum Cathepsin L as an Independent Biomarker in Patients With Coronary Heart Disease
- (2008) Yingxian Liu et al. AMERICAN JOURNAL OF CARDIOLOGY
- Parameter optimization in S-system models
- (2008) Marco Vilela et al. BMC Systems Biology
- Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression
- (2008) C. G. Kleer et al. CLINICAL CANCER RESEARCH
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Circulating cathepsin K and cystatin C in patients with cancer related bone disease: Clinical and therapeutic implications
- (2007) Francesca M. Tumminello et al. BIOMEDICINE & PHARMACOTHERAPY
- Cysteine cathepsin proteases as pharmacological targets in cancer
- (2007) Carmela Palermo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started